RELVAR 50 ELLIPTA 14 doses for Pediatric
- Manufacturer
- Glaxo Smith Kline K.K. (GSK)
- Packages
- Tags
Market information
Limited supply
- Update:
- Reason:
- Increased demand
- Lifting of shipments and elimination of supply is expected:
- Prospects
*This information is based on information released by the Ministry of Health, Labor and Welfare. This information may not be all-inclusive. Please check with the manufacturing companies for detailed information. Please note that the supply information does not necessarily correspond to our drug supply situation, and that the supply situation is constantly changing.
Detailed information
- Branded Name
-
RELVAR 50 ELLIPTA 14 doses for Pediatric
- Generic Name
- ビランテロールトリフェニル酢酸塩・フルチカゾンフランカルボン酸エステル吸入剤
- Heat Number / Carved Seal
- N/A
- Form / Color
- - / -
- Ministry of Health and Welfare Code
- 2290803G5023
- YJ Code
- 2290803G5023
- Manufacturer
- Glaxo Smith Kline K.K. (GSK)
- MA holder
- Glaxo Smith Kline K.K. (GSK)
- Restriction Information
- -
- Storage Condition
- -
- Cautions for Storage
- -
- Brand / Authorized Generic / Generic
- -
- Biological Origin / Biosimilar
- No
- Strength
- -
- Prescription Drug
- Yes
- Followed by Generic
- not available
- Effective date
- 000 00, 0000
- Lot No.
- 00000000
- Lead time
- X days
Log in or Sign up required.
Japanese notation
- Product Name
- 小児用レルベア５０エリプタ１４吸入用
- Name of Manufacturer
- グラクソ・スミスクライン
- Name of MA Holder
- グラクソ・スミスクライン
- Form / Color
- 吸入剤 / 白